Search Results
Search for other papers by Nora Sahnane in
Google Scholar
PubMed
Search for other papers by Daniela Furlan in
Google Scholar
PubMed
Search for other papers by Matilde Monti in
Google Scholar
PubMed
Search for other papers by Chiara Romualdi in
Google Scholar
PubMed
Search for other papers by Alessandro Vanoli in
Google Scholar
PubMed
Search for other papers by Emanuela Vicari in
Google Scholar
PubMed
Search for other papers by Enrico Solcia in
Google Scholar
PubMed
Search for other papers by Carlo Capella in
Google Scholar
PubMed
Search for other papers by Fausto Sessa in
Google Scholar
PubMed
Search for other papers by Stefano La Rosa in
Google Scholar
PubMed
patients had a history of primary pulmonary neuroendocrine neoplasms. Clinical information including sex, age, type of surgery, clinical history, the presence of distant metastases, and follow-up findings was collected by consulting clinical charts. This
Search for other papers by Mintallah Haider in
Google Scholar
PubMed
Search for other papers by Satya Das in
Google Scholar
PubMed
Search for other papers by Taymeyah Al-Toubah in
Google Scholar
PubMed
Search for other papers by Eleonora Pelle in
Google Scholar
PubMed
Search for other papers by Ghassan El-Haddad in
Google Scholar
PubMed
Search for other papers by Jonathan Strosberg in
Google Scholar
PubMed
)Yttrium and (177)Lutetium in 1048 patients with neuroendocrine neoplasm . Oncotarget 9 16932 – 16950 . ( https://doi.org/10.18632/oncotarget.24524 ) Bodei L Kidd M Paganelli G Grana CM Drozdov I Cremonesi M Lepensky C Kwekkeboom DJ
Search for other papers by Rushabh Gujarathi in
Google Scholar
PubMed
Search for other papers by Sara Abou Azar in
Google Scholar
PubMed
Search for other papers by Joseph Tobias in
Google Scholar
PubMed
Search for other papers by Blase N Polite in
Google Scholar
PubMed
Search for other papers by Namrata Setia in
Google Scholar
PubMed
Search for other papers by Nicholas Feinberg in
Google Scholar
PubMed
Search for other papers by Daniel E Appelbaum in
Google Scholar
PubMed
Search for other papers by Xavier M Keutgen in
Google Scholar
PubMed
Search for other papers by Chih-Yi Liao in
Google Scholar
PubMed
Introduction Well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs), the most common type of neuroendocrine neoplasms, are often metastatic at the time of presentation ( Yao et al. 2008 , Dasari et al. 2017 ). Peptide
Centre of Research on Inflammation, INSERM U1149, Paris, France
Search for other papers by Louis de Mestier in
Google Scholar
PubMed
Department of Pathology, ENETS Centre of Excellence, Bichat/Beaujon University Hospitals (APHP), and Université de Paris, Clichy/Paris, France
Search for other papers by Anne Couvelard in
Google Scholar
PubMed
Search for other papers by Anela Blazevic in
Google Scholar
PubMed
Search for other papers by Olivia Hentic in
Google Scholar
PubMed
Search for other papers by Wouter W de Herder in
Google Scholar
PubMed
Centre of Research on Inflammation, INSERM U1149, Paris, France
Search for other papers by Vinciane Rebours in
Google Scholar
PubMed
Department of Pathology, ENETS Centre of Excellence, Bichat/Beaujon University Hospitals (APHP), and Université de Paris, Clichy/Paris, France
Search for other papers by Valérie Paradis in
Google Scholar
PubMed
Centre of Research on Inflammation, INSERM U1149, Paris, France
Search for other papers by Philippe Ruszniewski in
Google Scholar
PubMed
Search for other papers by Leo J Hofland in
Google Scholar
PubMed
Department of Pathology, ENETS Centre of Excellence, Bichat/Beaujon University Hospitals (APHP), and Université de Paris, Clichy/Paris, France
Search for other papers by Jérôme Cros in
Google Scholar
PubMed
to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study . Endocrine 60 490 – 498 . ( https://doi.org/10.1007/s12020-017-1474-3 ) Candiloro ILM Dobrovic A 2009 Detection of MGMT
Search for other papers by Anela Blazevic in
Google Scholar
PubMed
Search for other papers by Martijn P A Starmans in
Google Scholar
PubMed
Search for other papers by Tessa Brabander in
Google Scholar
PubMed
Search for other papers by Roy S Dwarkasing in
Google Scholar
PubMed
Search for other papers by Renza A H van Gils in
Google Scholar
PubMed
Search for other papers by Johannes Hofland in
Google Scholar
PubMed
Search for other papers by Gaston J H Franssen in
Google Scholar
PubMed
Search for other papers by Richard A Feelders in
Google Scholar
PubMed
Faculty of Applied Sciences, Department of Radiology and Nuclear Medicine, Delft University of Technology, Delft, the Netherlands
Search for other papers by Wiro J Niessen in
Google Scholar
PubMed
Search for other papers by Stefan Klein in
Google Scholar
PubMed
Search for other papers by Wouter W de Herder in
Google Scholar
PubMed
predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms . British Journal of Cancer 117 1544 – 1550 . ( https://doi.org/10.1038/bjc.2017.315 ) Fortin JP Parker D Tunç B Watanabe T Elliott MA Ruparel
Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
Institute for Liver and Digestive Disease, Royal Free Hospital, University College London, London, UK
Search for other papers by Luohai Chen in
Google Scholar
PubMed
Search for other papers by Gopinath Gnanasegaran in
Google Scholar
PubMed
Search for other papers by Dalvinder Mandair in
Google Scholar
PubMed
Search for other papers by Christos Toumpanakis in
Google Scholar
PubMed
Search for other papers by Martyn Caplin in
Google Scholar
PubMed
Search for other papers by Shaunak Navalkissoor in
Google Scholar
PubMed
neuroendocrine neoplasms: a large series from a single institution . Neuroendocrinology 100 240 – 249 . ( https://doi.org/10.1159/000369818 ) Modlin IM Gustafsson BI Moss SF Pavel M Tsolakis AV Kidd M 2010 Chromogranin A – biological function and
Department of Molecular and Translational Medicine, Division of Biology and Genetics, University of Brescia, Brescia, Italy
Search for other papers by Chiara Alessandra Cella in
Google Scholar
PubMed
Metal Targeted Therapy & Immunology lab, Childrens’ cancer institute, Sydney, NSW, Australia
Search for other papers by Riccardo Cazzoli in
Google Scholar
PubMed
Search for other papers by Nicola Fazio in
Google Scholar
PubMed
Search for other papers by Giuseppina De Petro in
Google Scholar
PubMed
Search for other papers by Germano Gaudenzi in
Google Scholar
PubMed
Search for other papers by Silvia Carra in
Google Scholar
PubMed
Search for other papers by Mauro Romanenghi in
Google Scholar
PubMed
Search for other papers by Francesca Spada in
Google Scholar
PubMed
Search for other papers by Ilaria Grossi in
Google Scholar
PubMed
Search for other papers by Isabella Pallavicini in
Google Scholar
PubMed
Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy
Search for other papers by Saverio Minucci in
Google Scholar
PubMed
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by Giovanni Vitale in
Google Scholar
PubMed
Introduction Neuroendocrine neoplasms (NENs) constitute a highly heterogeneous spectrum of malignancies. In the majority of cases, they appear as well-differentiated or a low/intermediate grade of malignancy and are termed neuroendocrine
Search for other papers by Saya Ahmad in
Google Scholar
PubMed
Search for other papers by Myrthe R Naber in
Google Scholar
PubMed
Search for other papers by Rachel H Giles in
Google Scholar
PubMed
Search for other papers by Gerlof D Valk in
Google Scholar
PubMed
Search for other papers by Rachel S van Leeuwaarde in
Google Scholar
PubMed
patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs) . Surgery 142 814.e2 –81 8 .e 2 ( https://doi.org/10.1016/j.surg.2007.09.012 ) Bucau M Laurent-Bellue A Poté N Hentic O Cros J Mikail
ENETS Center of Excellence, Department of Endocrinology, University Hospital Basel, Basel, Switzerland
Department of Clinical Research, University of Basel, Basel, Switzerland
Search for other papers by Julie Refardt in
Google Scholar
PubMed
Search for other papers by Wouter T Zandee in
Google Scholar
PubMed
Search for other papers by Tessa Brabander in
Google Scholar
PubMed
Search for other papers by Richard A Feelders in
Google Scholar
PubMed
Search for other papers by Gaston J H Franssen in
Google Scholar
PubMed
Search for other papers by Leo J Hofland in
Google Scholar
PubMed
Department of Clinical Research, University of Basel, Basel, Switzerland
Search for other papers by Emanuel Christ in
Google Scholar
PubMed
Search for other papers by Wouter W de Herder in
Google Scholar
PubMed
Search for other papers by Johannes Hofland in
Google Scholar
PubMed
Introduction Neuroendocrine neoplasms (NENs) consist of a diverse group of tumors arising from neuroendocrine cells and are mainly localized in the intestine, pancreas and lung ( Hofland et al. 2020 ). Classification of NENs is based on
Search for other papers by Wenzel M Hackeng in
Google Scholar
PubMed
Search for other papers by Lodewijk A A Brosens in
Google Scholar
PubMed
Department of Endocrinology, Amsterdam University Medical Centers, VU University Medical Center, Amsterdam, The Netherlands
Search for other papers by Koen M A Dreijerink in
Google Scholar
PubMed
G Driessen A Peeters D Lawrence B Print C Peeters M Van Camp G 2020 PDX1 DNA methylation distinguishes two subtypes of pancreatic neuroendocrine neoplasms with a different prognosis . Cancers (Basel) 12 1461 . ( https://doi.org/10